Showing results (221-230 of 332) with videos related to
Sort By:
Pageof 34
Clinical Dysmorphology|May 8, 1998
Three patients with the osteochondrodysplasia and hypertrichosis syndrome--Cantu syndromeE M Rosser, H Kaariainen, J A Hurst, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Community permission for medical research in developing countriesDapa A Diallo, Ogobara K Doumbo, Christopher V Plowe, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 7, 2020
Squamous Cell Carcinoma of the Hand: A Retrospective Study in Immunosuppressed and Immunocompetent IndividualsJamie L Mull, Patrick S Phelan, Aaron B Mull, et al.Journal of Photochemistry and Photobiology. B, Biology|March 4, 2014
Malondialdehyde-derived epitopes in human skin result from acute exposure to solar UV and occur in nonmelanoma skin cancer tissueJoshua D Williams, Yira Bermudez, Sophia L Park, et al.Nephrology (Carlton, Vic.)|March 12, 2008
Extracellular signal-regulated kinase-dependent interstitial macrophage proliferation in the obstructed mouse kidneyYingjie Han, Takao Masaki, Lynette A Hurst, et al.BMC Women'S Health|March 21, 2021
Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative studyAgatha K Bula, Kendra Hatfield-Timajchy, John Chapola, et al.Diabetologia|May 26, 2009
Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db miceA K H Lim, F Y Ma, D J Nikolic-Paterson, et al.AJR. American Journal of Roentgenology|July 1, 1979
Pulmonary manifestations of Mycobacterium intracellularisE E Christensen, G W Dietz, C H Ahn, et al.Clinical and Experimental Immunology|September 6, 2000
Up-regulation of the tumour-associated marker CD44V6 in experimental kidney diseaseK Takazoe, R Foti, G H Tesch, et al.Journal of Cutaneous Pathology|March 20, 2014
Histopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanomaKari E Sufficool, Donna M Hepper, Gerald P Linette, et al.Pageof 34